home / stock / khtrf / khtrf news

KHTRF News and Press, Knight Therapeutics Inc From 11/12/19

Stock Information
Company Name: Knight Therapeutics Inc
Stock Symbol: KHTRF
Market: OTC
Website: gud-knight.com
Menu
KHTRF KHTRF Quote KHTRF Short KHTRF News KHTRF Articles KHTRF Message Board
Get KHTRF Alerts

News, Short Squeeze, Breakout and More Instantly...
KHTRF - Knight Therapeutics reports Q3 results

Knight Therapeutics ( OTC:KHTRF ): Q3 GAAP EPS of -C$0.021. More news on: Knight Therapeutics Inc., Earnings news and commentary, Read more ...

KHTRF - Knight to acquire Latin American pharma firm for C$369M

Knight Therapeutics ( OTC:KHTRF ) has agreed to acquire Montevideo, Uruguay-based Biotoscana Investments S.A. ("Grupo Biotoscana") for BRL 1,164M (C$369M). More news on: Knight Therapeutics Inc., Healthcare stocks news, Merger & acquisition news, Read more ...

KHTRF - Knight Therapeutics Inc. (KHTRF) CEO Jonathan Ross Goodman on Q2 2019 - Earnings Call Transcript

Knight Therapeutics Inc. (KHTRF) Q2 2019 Earnings Conference Call August 08, 2019, 08:30 AM ET Company Participants Jonathan Ross Goodman - CEO Samira Sakhia - President and CFO Amal Khouri - VP, Business Development Arvind Utchanah - VP, Finance Conference Call Participants...

KHTRF - Knight Therapeutics reports Q2 results

Knight Therapeutics ( OTC:KHTRF ): Q2 GAAP EPS of C$0.13. More news on: Knight Therapeutics Inc., Earnings news and commentary, Read more ...

KHTRF - Knight Therapeutics Inc. (KHTRF) CEO Jonathan Ross Goodman on Q1 2019 Results - Earnings Call Transcript

Knight Therapeutics Inc. (KHTRF) Q1 2019 Earnings Conference Call May 09, 2019 08:30 AM ET Company Participants Jonathan Ross Goodman - CEO Samira Sakhia - CFO Amal Khouri - VP, Business Development Presentation Operator Good morning, ladies and gentlemen. My name is Ju...

KHTRF - Knight Therapeutics reports Q1 results

Knight Therapeutics ( OTC:KHTRF ): Q1 GAAP EPS of C$0.04. More news on: Knight Therapeutics Inc., Earnings news and commentary, Read more ...

KHTRF - Knight Therapeutics Inc. (KHTRF) CEO Jonathan Ross Goodman on Q4 2018 Results - Earnings Call Transcript

Knight Therapeutics Inc. (KHTRF) Q4 2018 Earnings Conference Call March 14, 2019 08:30 AM ET Company Participants Jonathan Ross Goodman - Chief Executive Officer Samira Sakhia – President & Chief Financial Officer Amal Khouri - Vice President of Business Development ...
KHTRF - Knight Therapeutics reports Q4 results

Knight Therapeutics ( OTC:KHTRF ): Q4 GAAP EPS of C$0.00. More news on: Knight Therapeutics Inc., Earnings news and commentary, Read more ...

Previous 10 Next 10